$BBAI Balance Sheet | Understand Stock

$BBAI

$2.28 -$0.07 (2.98%) Pre-market

$BBAI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash
Prepaid expenses
Receivable from related party
Cash and cash equivalents
Held-to-maturity investments, at amortized cost (fair value of $130,159 at September 30, 2025 and $— at December 31, 2024)
Restricted cash
Available for sale investments, at fair value (amortized cost of $283,385 at June 30, 2026 and $200,468 at December 31, 2025)
Accounts receivable, less allowance for credit losses of $131 as of June 30, 2026 and $438 as of December 31, 2025
Contract assets
Prepaid expenses and other current assets
Total current assets

Cash and marketable securities held in Trust Account
Interest receivable on cash and marketable securities held in Trust Account
Non-current assets:
Property and equipment, net
Goodwill
Intangible assets, net
Held-to-maturity investments, at amortized cost (fair value of $128,871 at September 30, 2025 and $— at December 31, 2024)
Available for sale investments, at fair value (amortized cost of $91,010 at June 30, 2026 and $173,789 at December 31, 2025)
Right-of-use assets
Deferred tax assets
Other non-current assets
Total assets

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
Payable to related parties
Current portion of long-term debt, net
Accrued liabilities
Contract liabilities
Current portion of long-term lease liability
Derivative liabilities
Other current liabilities
Total current liabilities

Warrant liability
Deferred underwriting fee payable
Non-current liabilities:
Long-term debt, net
Long-term lease liability
Deferred tax liabilities
Other non-current liabilities
Total liabilities
Common stock subject to possible redemption, 35,880,000 shares as of September 30, 2021, at a redemption value of $10.00 per share
Stockholders’ equity
Common stock, par value $0.0001; 1,000,000,000 shares authorized and 479,494,493 shares issued and outstanding at June 30, 2026 and 500,000,000 shares authorized and 436,955,655 shares issued and outstanding at December 31, 2025
Additional paid-in capital
Treasury stock, at cost 9,952,803 shares at March 31, 2022 and — shares at December 31, 2021
Treasury stock, at cost; zero shares at June 30, 2026 and 9,952,803 shares at December 31, 2025
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity

Total liabilities and stockholders’ equity

Treasury stock, shares (in shares)

Comments